Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function

被引:0
|
作者
Giuntoli, RL
Lu, J
Kobayashi, H
Kennedy, R
Celis, E
机构
[1] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA
[3] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The survival and proliferation of CTL during the effector phase of the immune response is critical for the elimination of infectious agents and tumor cells. We report here that in an in vitro model system, the expansion and cytolytic function of tumor-reactive human CTL can be enhanced by CD4(+) helper T lymphocytes through costimulatory signals that are mediated by cell surface molecules. The results presented here suggest that costimulatory receptors on CTL such as CD27, CD134 (4-1BB), and MHC class 11 are capable of directly interacting with the corresponding ligands on T-helper lymphocytes resulting in enhanced proliferation and survival of the CTL during the effector phase of antitumor immune responses. These findings underline the importance of antigen-specific helper T lymphocytes for the regulation and maintenance of CTL immunity, and have implications for the design of therapeutic vaccines for cancer.
引用
收藏
页码:922 / 931
页数:10
相关论文
共 50 条
  • [1] Helper T cells potentiate the effector function and growth of anti-tumor cytotoxic T lymphocytes
    Giuntoli, RL
    Lu, J
    Kennedy, R
    Kobayashi, H
    Celis, E
    FASEB JOURNAL, 2001, 15 (04): : A662 - A662
  • [2] Tumor-reactive T helper cells in the context of vaccination against glioma
    Zhao, Binghao
    Kilian, Michael
    Bunse, Theresa
    Platten, Michael
    Bunse, Lukas
    CANCER CELL, 2023, 41 (11) : 1829 - 1834
  • [3] CD4 tumor-reactive T cells enhance intratumoral proliferation and effector function of CD8 cells and synergistically mediate tumor regression.
    Wang, Li-Xin
    Shu, Suyu
    Plautz, Gregory E.
    CANCER RESEARCH, 2006, 66 (08)
  • [4] Effects of tumor necrosis factor-α on the in vitro maturation of tumor-reactive effector T cells
    Tanigawa, K
    Craig, RA
    Stoolman, LM
    Chang, AE
    JOURNAL OF IMMUNOTHERAPY, 2000, 23 (05) : 528 - 535
  • [5] Tumor-reactive CD4+ T cells: plasticity beyond helper and regulatory activities
    Quezada, Sergio A.
    Peggs, Karl S.
    IMMUNOTHERAPY, 2011, 3 (08) : 915 - 917
  • [6] Regulatory T cells reversibly suppress cytolytic function, but not effector differentiation, of tumor-reactive CD8 T cells in tumor-draining lymph nodes
    Mempel, Thorsten
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 667 - 667
  • [7] Tumor-associated galectin-3 modulates the function of tumor-reactive T cells
    Peng, Weiyi
    Wang, Helen Y.
    Miyahara, Yoshihiro
    Peng, Guangyong
    Wang, Rong-Fu
    CANCER RESEARCH, 2008, 68 (17) : 7228 - 7236
  • [8] Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells
    Hamaidi, Imene
    Zhang, Lin
    Kim, Nayoung
    Wang, Min-Hsuan
    Iclozan, Cristina
    Fang, Bin
    Liu, Min
    Koomen, John M.
    Berglund, Anders E.
    Yoder, Sean J.
    Yao, Jiqiang
    Engelman, Robert W.
    Creelan, Ben C.
    Conejo-Garcia, Jose R.
    Antonia, Scott J.
    Mule, James J.
    Kim, Sungjune
    CELL METABOLISM, 2020, 32 (03) : 420 - +
  • [9] Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression
    Huang, JP
    Khong, HT
    Dudley, ME
    El-Gamil, M
    Li, YF
    Rosenberg, SA
    Robbins, PF
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (03) : 258 - 267
  • [10] Tumor-Reactive CD8+ Early Effector T Cells Identified at Tumor Site in Primary and Metastatic Melanoma
    Anichini, Andrea
    Molla, Alessandra
    Vegetti, Claudia
    Bersani, Ilaria
    Zappasodi, Roberta
    Arienti, Flavio
    Ravagnani, Fernando
    Maurichi, Andrea
    Patuzzo, Roberto
    Santinami, Mario
    Pircher, Hanspeter
    Di Nicola, Massimo
    Mortarini, Roberta
    CANCER RESEARCH, 2010, 70 (21) : 8378 - 8387